Investors / OrbiMed
OrbiMed
OrbiMed is a venture capital firm based in the United States. OrbiMed has backed 2 Canadian AI companies in the Index, joining 3 tracked rounds and leading 2. The most recent was Altis Labs's US$25M Series A in September 2026. OrbiMed most often invests alongside Lumira Ventures, Amplitude Ventures and BDC Thrive Venture Fund.
VC based in US. 2 Canadian AI companies in the Index, 3 tracked rounds, 2 as lead.
- Type
- VC
- HQ country
- US
- Companies
- 2
- Tracked rounds
- 3
- Led
- 2
- First tracked deal
- Congruence Therapeutics, Sep 2025
- Latest tracked deal
- Altis Labs, Sep 2026
Portfolio
| Company | Rounds joined (date, round size) | Company's total raised | Role |
|---|---|---|---|
| Altis Labs | Series A · Sep 2026 · US$25M round (lead) | US$31M | Lead |
| Congruence Therapeutics | Venture round · Sep 2025 · US$32M roundVenture round · Mar 2026 · US$39.5M round (lead) | US$71.5M | Led a venture round |
A round's size is the whole round as announced, not this investor's cheque.
Frequent co-investors
Lumira Ventures (3 shared rounds), Amplitude Ventures (2 shared rounds), BDC Thrive Venture Fund (2 shared rounds), Driehaus Capital Management (2 shared rounds), Fonds de solidarité FTQ (2 shared rounds), Investissement Québec (2 shared rounds), Silver Arc Capital (2 shared rounds), Alexandria Venture Investments (1 shared round)
Data as of November 10, 2026.